In this study, we show that high expression of NOTCH1 was strongly associated with ICB survival among SCLC patients with ASCL1- and NEUROD1-enriched tumors, the most common subsets constituting approximately 80% of all SCLC tumors. Here, ASCL1 is linked to small cell lung carcinoma.